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aBstraCt
Combined hamartoma of the retina and retinal pigment epithelium (CHRRPE) is a rare, benign, usually one-
sided disease that can cause significant painless vision loss. Combined hamartoma of the retina and retinal pigment 
epithelium  is most commonly found in isolated forms, but reports are also available describing compounds with 
neurofibromatosis types 1 and 2. CHRRPE has increased retinal pigmentation, tortuous vessels, and the presence 
of epiretinal membranes.
In our article, we present a case report of a 6-year-old girl who was diagnosed with CHRRPE.
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introduCtion
Combined hamartoma of the retina and retinal 
pigment epithelium (CHRRPE) is a rare, benign, 
usually one-sided tumor that can cause signifi-
cant painless vision loss and strabismus. Com-
bined hamartoma of the retina and retinal pigment 
epithelium is most commonly found in isolated 
forms, but reports are also available describing 
compounds with neurofibromatosis types 1 and 
2. The classic clinical symptoms of CHRRPE in-
creased retinal pigmentation, tortuous vessels, and 
the presence of epiretinal membranes. The diag-
nosis of CHRRPE is established by combining 
classic clinical signs with diagnostic features on 
ultrasonography (noncalcified mass) and pleated, 
thickened retina with disorganized of the photore-
ceptor on optical coherence tomography (OCT). 
This tumor can resemble choroidal melanoma 
or retinoblastoma.
We report a case of CHRRPE with poor visual 
acuity and strabismus.
Case report
A 6-year-old girl was admitted to the Ophthal-
mological Emergency Room due to slow, painless 
decrease of visual acuity in the left eye and left eye 
esotropia. The mother of the girl did not notice the 
beginning of the deterioration of vision and the 
incorrect position of the left eye. Parents denied 
the injury, the child’s general health was normal, 
the girl was born without complications at de-
livery. On exam, the best-corrected visual acuity 
was 20/20 OD and 20/250 OS. The anterior seg-
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ment was unremarkable OU. In the fundoscopy 
of the left eye, an area of increased pigmentation 
of the retinal pigment epithelium was observed, 
vascular arcades were distorted and shifted towards 
the macula. Within the lesion a shimmering gray 
epiretinal membrane was visible. The retinal pe-
riphery was normal (Fig. 1). There wasno deviation 
in the fundoscopy of the right eye. Optical coher-
ent tomography of the left eye showed a significant 
thickening of the retina with hyporeflective shad-
ing of normal retinal layers and with the presence 
of the epiretinal membrane. The right eye OCT 
was normal (Fig. 2). Type B ultrasound showed 
a lobular lesion in the macula region with a calci-
fied plaque on the lesion surface. The patient was 
referred to the Ophthalmological Oncology Clin-
ic in Cracow where the diagnosis was confirmed 
based on a clinical examination and additional 
tests, i.e. OCT, ultrasound. The patient remains 
under constant ophthalmological control, her con-
dition is stable.
disCussion
Embryologically, the retinal pigment epithelium 
(RPE) develops from the outer layer of the optic 
cup — the ectoderm, and the neurosensory retina 
from the inner layer. In the inner layer, the cells 
adherent to the intraretinal space differentiates into 
photoreceptors and the cells of the next layer form 
Muller cells as well as bipolar cells and ganglion cell 
axons. Retinal and pigmented epithelial hamartoma 
is, therefore, a congenital lesion in which the de-
velopmental disorders of all separately developing 
retinal layers occurs [1, 2].
Histologically, CHRRPE consists of pig-
mented, glial and vascular cells in various propor-
Figure 2. optical coherent tomography (oCt) of the left eye showed a significant thickening of the retina with hyporeflective shading of 
normal retinal layers and with the presence of the epiretinal membrane. the right eye oCt was normal
Figure 1. In the fundoscopy of the left eye, an area of increased 
pigmentation of the retinal pigment epithelium was observed, 
vascular arcades were distorted and shifted towards the macula. 
Within the lesion a shimmering gray epiretinal membrane was 
visible
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tions. It is most often located near the optic nerve 
(76%), macula (17%) and in the peripheral retina 
(17%) [3].
Gass was the first to use the term retinal hamar-
toma and RPE in 1973. He was the first to describe 
clinical features of CHRRRPE as:
 — slightly elevated dark gray lesion affecting the 
retina, RPE and surrounding vitreous;
 — expansion towards the peripher;
 — connecting to the neighboring RPE;
 — surrounded by dense gray-white retina;
 — showing internal surface compression;
 — without peripheral RPE and choroidal atrophy;
 — no retinal detachment, haemorrhage, vitreous 
effusion [4].
According to Gass, CHRRPE was initially di-
vided into two subcategories depending on the pres-
ence or absence of involvement of the optic disc. [5] 
These two types of CHRRPE have slightly different 
histological features. CHRRPE, which does not in-
clude the optic disc, shows no RPE cell migration, 
less RPE overgrowth, less retinal capillary prolifera-
tion, and less retinal disorganization.
Based on current imaging studies, including op-
tical coherent tomography (OCT), common fea-
tures of CHRRPE lesions include tumor involve-
ment of the internal and intermediate layers of the 
retina (the inner layer of the retina to the outer 
plexus layer) with varying amounts of thickened 
gray-white retinal tissues and epiretinal membranes, 
the displacement of the surrounding retina and 
blood vessels, no choroid involvement [6, 7].
In 2018 Dedania et al. proposed a new clini-
cal classification system for the assessment and fol-
low-up of patients with CHRRPE. The use of a uni-
form classification system is intended to facilitate 
the assessment and comparison of the results of vari-
ous tests, to determine the frequency of follow-up 
visits and/or to take therapeutic measures. Changes 
are classified based on location, fundus features 
and OCT.
Location of the lesion: zone 1 — macu-
la/per-macular zone, zone 2 — medium retinal pe-
riphery, zone 3 — distal retinal periphery.
Retinal assessment during fundoscopy: stage 
1 — no retinal vitreous traction, stage 2 — the 
presence of retinal traction and/or dissection, stage 
3 — retinal detachment.
Retinal morphology in OCT: A — epiretinal 
membrane, B — changes in the deeper layers of the 
retina, and C — changes on the entire retinal thick-
ness and in RPE.
In patients under 12 years, a full ophthalmologic 
and morphological assessment is recommended at 
least every 6 months, with more frequent observa-
tion (2–4 months) in patients with macular/per-
imacular lesions (zone 1) or with retinal traction, 
dissection or detachment retina (stages 2 and 3). 
Surgical intervention is recommended in patients 
with deterioration or loss of vision secondary to reti-
nal vitreous traction or retinal detachment. Routine 
assessment in patients with lesions in zone 3 is less 
common, every 6 or every 12 months, depending 
on the stage of the change [8].
There are no known risk factors. The Caucasian 
breed seems to dominate. As for gender, in the study 
by Schachat et al. men and women were equally 
affected (31 men and 29 women) [9]. However, in 
the article Shields et al. the majority of patients were 
men (68%). 
Shields et al. report the most common present-
ing signs were decreased vision (40%) and strabis-
mus (28%) in 79 eyes with CHRRPE in a retro-
spective analysis. The mean vision (logMAR) for the 
macular tumors’ location (51%) was 1.2, compared 
with 0.61 in patients with extramacular tumors 
location (49%). At 4 years follow-up, visual acuity 
loss of 3 Snellen lines or more appeared in 60% of 
patients with macular CHRRPE, compared with 
13% of peripheral CHRRPE [10]. The visual acuity 
loss and strabismus are the most frequent presenting 
signs as in our patient.
CHRRPE are usually unilateral changes. Bi-
lateral lesions are more commonly associated with 
phacomatoses, including NF type 1, NF type 2, 
tuberous sclerosis and basal cell nevus syndrome 
[11, 12]. Although CHRRPE is more common in 
patients with NF type 2, in practice these changes 
are more commonly seen in patients with NF type 
1 due to the higher incidence of NF1. [11] It 
is recommended to perform genetic tests in pa-
tients diagnosed with CHRRPE, especially in 
patients with binocular presence of characteristic 
lesions. In hamartomic differentiation, retinoblas-
toma, melanoma, RPE adenoma, RPE adenocarci-
noma should be considered.
ConClusions
Classical clinical symptoms, as a painless loss of 
vision, combined with fundoscopy and diagnostic 
imaging using optical coherence tomography, allow 
diagnosis of the disease. The highest risk of blind-
ness or loss of vision are in the presence of CHR-
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RPE with macular/perimacular region involvement 
with simultaneous retinal vitreous traction, retinal 
detachment or dissection.
Assessment of anatomy and morphology of the 
lesion allows it to be properly classified. This fa-
cilitates observation of the patient, determining the 
time interval between subsequent controls and the 
inclusion of early therapeutic intervention that can 
protect against vision loss.
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